Updated Date:
26 Mar 2026
Product Detail:
EDRONAX reboxetine 4mg (as mesilate) tablet blister pack
Shortage Status:
Anticipated
AUST R:
79745
Availability:
Available
Active Ingredient:
reboxetine mesilate
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Tablet,uncoated
Supply Impact Dates
From 24 Aug 2026
To 01 Oct 2026
Management Action:
The sponsor is working to expedite the next shipment.